Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Net Margin (2021 - 2025)

Historic Net Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 168555828.11%.

  • Molecular Partners Ag's Net Margin fell 1685541632100.0% to 168555828.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 263372.74%, marking a year-over-year decrease of 2623443200.0%. This contributed to the annual value of 1080.86% for FY2024, which is 8854846334300.0% up from last year.
  • As of Q3 2025, Molecular Partners Ag's Net Margin stood at 168555828.11%, which was down 1685541632100.0% from 1286.17% recorded in Q1 2025.
  • Molecular Partners Ag's 5-year Net Margin high stood at 486415.0% for Q4 2021, and its period low was 168555828.11% during Q3 2025.
  • In the last 5 years, Molecular Partners Ag's Net Margin had a median value of 501.47% in 2022 and averaged 9337135.43%.
  • Per our database at Business Quant, Molecular Partners Ag's Net Margin skyrocketed by 137605300bps in 2023 and then plummeted by 2000000000bps in 2025.
  • Over the past 5 years, Molecular Partners Ag's Net Margin (Quarter) stood at 486415.0% in 2021, then crashed by -100bps to 62.15% in 2022, then surged by 22140bps to 13822.69% in 2023, then tumbled by -99bps to 144.66% in 2024, then crashed by -116516080bps to 168555828.11% in 2025.
  • Its Net Margin was 168555828.11% in Q3 2025, compared to 1286.17% in Q1 2025 and 144.66% in Q4 2024.